| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 6.185 | 118.005 | 135.675 | 165.011 | 180.365 | 239.095 | 276.312 |
| Total Income - EUR | - | - | - | 6.185 | 118.006 | 136.174 | 165.152 | 180.903 | 239.581 | 276.895 |
| Total Expenses - EUR | - | - | - | 4.533 | 80.022 | 78.129 | 109.138 | 154.695 | 206.488 | 222.810 |
| Gross Profit/Loss - EUR | - | - | - | 1.653 | 37.984 | 58.046 | 56.014 | 26.208 | 33.093 | 54.085 |
| Net Profit/Loss - EUR | - | - | - | 1.591 | 36.804 | 56.689 | 54.395 | 24.670 | 31.057 | 46.193 |
| Employees | - | - | - | 2 | 3 | 3 | 1 | 5 | 0 | 5 |
Check the financial reports for the company - Podoline Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 147 | 50 | 45 | 45 | 30 | 11.660 | 13.183 |
| Current Assets | - | - | - | 2.554 | 49.443 | 79.779 | 80.598 | 65.751 | 52.006 | 66.905 |
| Inventories | - | - | - | 27 | 0 | 4.617 | 3.584 | 5.787 | 5.562 | 15.092 |
| Receivables | - | - | - | 290 | 1.043 | 1.629 | 14.004 | 40.589 | 45.905 | 50.924 |
| Cash | - | - | - | 2.237 | 48.400 | 73.532 | 63.010 | 19.374 | 539 | 890 |
| Shareholders Funds | - | - | - | 1.634 | 38.406 | 57.716 | 54.443 | 26.788 | 35.183 | 48.288 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 1.067 | 11.087 | 22.108 | 26.199 | 39.038 | 26.217 | 31.923 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 2.378 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Podoline Med S.r.l.